20Med Therapeutics
PrivateLast Round
Grant
Feb 2, 2023
Total Funding Raised
$850,000
Company Overview
20Med Therapeutics is a biotechnology company that develops RNA and DNA-based vaccines and therapeutics using a proprietary bio-responsive polymeric nanoparticle platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
20Med Therapeutics Comparables
Compare 20Med Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xanadu Bio | 82% | |
| Nanite, Inc. | 81% | |
| ACM Biolabs | 80% | |
20Med Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 2, 2023 | ||||
| Grant | Jul 24, 2019 | ||||
| Seed | Nov 2, 2017 |
20Med Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| European Commission | Grant |
| Twente Technology Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 23, 2023
Grew 21% QoQ, from 14 to 17 employees.
- Nov 2, 2017
Twente Technology Fund and innovatiefonds-twente participated in the round.
20Med Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 20Med Therapeutics's valuation, stock price, and market status.